Gain full access to the latest clinical content available from Springer Nature
23-08-2017 | E-learning | Collection
Treatment with biologicals in rheumatoid arthritis: An overview
The present review focuses on biological disease-modifying antirheumatic drugs (DMARDs) and targeted synthetic DMARDs regarding similarities and possible drug-specific advantages in the treatment of rheumatoid arthritis.
Credit available: 1 (one) AMA PRA Category 1 Credit™
Valid until: August 2018
Latest from across the site
Neuer Inhalt, Treatment with biologicals in rheumatoid arthritis: An overview, Files/© jdwfoto / iStock / Thinkstock, Exercise/© panthermedia, Exercise/© panthermedia, Marc D Cohen picture, Oliver FitzGerald picture, Philip Mease, Fernando Pérez-Ruiz picture, Victoria Ruffing, Sangeeta Sule